Yu Qi

1.5k total citations
34 papers, 889 citations indexed

About

Yu Qi is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu Qi has authored 34 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cancer Research, 26 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu Qi's work include Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (16 papers) and Circular RNAs in diseases (11 papers). Yu Qi is often cited by papers focused on Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (16 papers) and Circular RNAs in diseases (11 papers). Yu Qi collaborates with scholars based in China and United Kingdom. Yu Qi's co-authors include Yiran Huang, Jia Li, Bing Liu, Chun‐yang Zhang, Donglei Liu, Dengyan Zhu, Kai Wu, Yang Xiao, Qianqian Liu and Shimeng Pan and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Yu Qi

32 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Qi China 17 693 629 102 92 82 34 889
Long Wu China 17 771 1.1× 634 1.0× 103 1.0× 126 1.4× 147 1.8× 54 1.1k
Yongbing Wu China 14 530 0.8× 343 0.5× 84 0.8× 99 1.1× 110 1.3× 35 710
Hiroko Mataki Japan 14 594 0.9× 545 0.9× 94 0.9× 42 0.5× 70 0.9× 16 779
Qingping Jiang China 17 601 0.9× 502 0.8× 58 0.6× 83 0.9× 154 1.9× 43 833
Xiaosong Ge China 12 566 0.8× 536 0.9× 59 0.6× 83 0.9× 135 1.6× 35 820
Chenlong Song China 9 778 1.1× 528 0.8× 84 0.8× 49 0.5× 146 1.8× 11 1.0k
Qiurong Ye China 13 401 0.6× 332 0.5× 64 0.6× 157 1.7× 169 2.1× 20 679
Francesca Fanini Italy 14 882 1.3× 716 1.1× 89 0.9× 120 1.3× 159 1.9× 25 1.1k

Countries citing papers authored by Yu Qi

Since Specialization
Citations

This map shows the geographic impact of Yu Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Qi more than expected).

Fields of papers citing papers by Yu Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Qi. The network helps show where Yu Qi may publish in the future.

Co-authorship network of co-authors of Yu Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Qi. A scholar is included among the top collaborators of Yu Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Qi. Yu Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Jiaxi, Qi Bai, Yuan Huang, et al.. (2025). Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses. Nature Communications. 16(1). 1425–1425. 5 indexed citations
2.
He, Yikun, Yu Qi, Guoan Zhao, et al.. (2024). Investigating disturbances of the core material system in the lung-gut axis of COPD based on the transcriptomics-metabolomics-microbiomics integration strategy. Arabian Journal of Chemistry. 18(1). 106056–106056. 1 indexed citations
3.
Ma, Chao, Feng Li, Zhuoyu Gu, Yang Yang, & Yu Qi. (2023). A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma. Frontiers in Pharmacology. 14. 1146840–1146840. 13 indexed citations
4.
Li, Mengmeng, Lei Jiao, Yingchun Shao, et al.. (2022). LncRNA-ZFAS1 Promotes Myocardial Ischemia-Reperfusion Injury Through DNA Methylation-Mediated Notch1 Down-Regulation in Mice. JACC Basic to Translational Science. 7(9). 880–895. 22 indexed citations
5.
Qi, Yu, et al.. (2021). Exosome-derived SNHG16 sponging miR-4500 activates HUVEC angiogenesis by targeting GALNT1 via PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Journal of Physiology and Biochemistry. 77(4). 667–682. 40 indexed citations
6.
Wu, Chunli, et al.. (2021). SPTBN2, a New Biomarker of Lung Adenocarcinoma. Frontiers in Oncology. 11. 754290–754290. 10 indexed citations
7.
Dong, Bo, Chunli Wu, Lan Huang, & Yu Qi. (2021). Macrophage-Related SPP1 as a Potential Biomarker for Early Lymph Node Metastasis in Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 739358–739358. 43 indexed citations
8.
Qi, Yu, Yujia Shan, Yiran Huang, et al.. (2021). LncRNA LEF1-AS1/LEF1/FUT8 Axis Mediates Colorectal Cancer Progression by Regulating α1, 6-Fucosylationvia Wnt/β-Catenin Pathway. Digestive Diseases and Sciences. 67(6). 2182–2194. 15 indexed citations
9.
Zhao, Xinyu, Yue Pan, Yu Qi, et al.. (2020). The lncRNA MEG3 mediates renal cell cancer progression by regulating ST3Gal1 transcription and EGFR sialylation. Journal of Cell Science. 133(16). 23 indexed citations
10.
Liu, Bing, Qianqian Liu, Shimeng Pan, et al.. (2019). The HOTAIR/miR-214/ST6GAL1 crosstalk modulates colorectal cancer procession through mediating sialylated c-Met via JAK2/STAT3 cascade. Journal of Experimental & Clinical Cancer Research. 38(1). 455–455. 63 indexed citations
11.
Wu, Kai, Jiachen Li, Yu Qi, et al.. (2019). SNHG14 confers gefitinib resistance in non-small cell lung cancer by up-regulating ABCB1 via sponging miR-206-3p. Biomedicine & Pharmacotherapy. 116. 108995–108995. 39 indexed citations
12.
Xiong, Ying, Yu Qi, Qi Bai, et al.. (2019). Relevance of arm somatic copy number alterations for oncologic outcomes and tumor immune microenvironment in clear cell renal cell carcinoma. Annals of Translational Medicine. 7(22). 646–646. 7 indexed citations
13.
Qi, Yu, Nana Zhang, Yan Jiang, et al.. (2018). RGS17 inhibits tumorigenesis and improves 5-fluorouracil sensitivity in nasopharyngeal carcinoma. SHILAP Revista de lepidopterología.
14.
Zhang, Chun‐yang, Ren‐Ke Li, Yu Qi, et al.. (2016). Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial–mesenchymal transition. Cell Biology and Toxicology. 32(5). 391–401. 29 indexed citations
15.
Guo, Wenna, Qiang Wang, Yueping Zhan, et al.. (2016). Transcriptome sequencing uncovers a three–long noncoding RNA signature in predicting breast cancer survival. Scientific Reports. 6(1). 27931–27931. 61 indexed citations
16.
Zhu, Dengyan, Yu Qi, Donglei Liu, et al.. (2016). MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN. Biomedicine & Pharmacotherapy. 81. 79–85. 56 indexed citations
17.
Guo, Wenna, Ying Zhang, Yueping Zhan, et al.. (2015). High-throughput sequencing and degradome analysis reveal neutral evolution of Cercis gigantea microRNAs and their targets. Planta. 243(1). 83–95. 10 indexed citations
18.
Liu, Zhen, Yu Qi, Yongliang Hu, et al.. (2014). Analysis of miRNA expression profiling in human macrophages responding to Mycobacterium infection: Induction of the immune regulator miR-146a. Journal of Infection. 68(6). 553–561. 60 indexed citations
19.
Qi, Yu. (2010). Expression of HIF-1α and E2F6 protein in cervical carcinoma tissues. 1 indexed citations
20.
Qi, Yu, Benli Su, Dandan Liu, et al.. (2007). Antisense RNA-Mediated Suppression of Bmi-1 Gene Expression Inhibits the Proliferation of Lung Cancer Cell Line A549. Oligonucleotides. 17(3). 327–335. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Long Wu Breakdown of academic impact, for papers by Yongbing Wu Breakdown of academic impact, for papers by Hiroko Mataki Breakdown of academic impact, for papers by Qingping Jiang Breakdown of academic impact, for papers by Xiaosong Ge Breakdown of academic impact, for papers by Chenlong Song Breakdown of academic impact, for papers by Qiurong Ye Breakdown of academic impact, for papers by Francesca Fanini
Rankless by CCL
2026